Rogaine
Developed to support hair regrowth to address hair thinning.
Strengths: 5 · 10%
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Regaine
- Therapeutic class
Hair Growth Stimulant
- Pharmacological class
Vasodilator
- Contraindications
hypersensitivity to minoxidil; pheochromocytoma; damaged or inflamed scalp
- Minor side effects
erythema; pruritus; dermatitis; hypertrichosis
- Moderate side effects
scalp dryness; local irritation
- Dosage forms
Cutaneous solution; Cutaneous foam
- Administration route
Cutaneous use
- Patient summary
Developed to support hair regrowth to address hair thinning.
- Prescription status
P
- Manufacturer
Johnson & Johnson
- Onset Time
2–4 months
- Duration
continuous use required
- Storage instructions
Store at room temperature; keep container tightly closed.
- Age restrictions
Not for use by individuals under 18 years.
Precautions and warnings
avoid contact with eyes; discontinue if systemic effects occur; avoid exposure to open flame due to flammability of formulation
Serious side effects
tachycardia — requires immediate medical attention; hypotension — requires immediate medical attention
Mechanism of action
Induces vasodilation in scalp vessels and prolongs the anagen (growth) phase of hair follicles to improve thickness and hair density.
Pregnancy and breastfeeding
Pregnancy: Generally contraindicated. Breastfeeding: Consult a physician before use.
Rogaine
Developed to support hair regrowth to address hair thinning.
Editorial Notes
- Active ingredient(s): Minoxidil
- Listed indication(s): Androgenetic Alopecia